OpenAlex · Aktualisierung stündlich · Letzte Aktualisierung: 27.03.2026, 08:51

Bristol-Myers Squibb (United States)

22.014 Arbeiten4.314.301 Zitationen
Land: USTyp: company

Relevante Arbeiten

Meistzitierte Publikationen im Bereich Gesundheit & MedTech

Digital pathology and artificial intelligence in translational medicine and clinical practice

Vipul Baxi, Robin Edwards, Michael Montalto et al.

2021 · 525 Zit.

Artificial Intelligence to Automate Network Meta-Analyses: Four Case Studies to Evaluate the Potential Application of Large Language Models

Tim Reason, Emma Benbow, Julia Langham et al.

2024 · 55 Zit.

A platform for the biomedical application of large language models

Sebastian Lobentanzer, Shaohong Feng, Noah Bruderer et al.

2025 · 43 Zit.

Artificial Intelligence to Automate Health Economic Modelling: A Case Study to Evaluate the Potential Application of Large Language Models

Tim Reason, William D. Rawlinson, Julia Langham et al.

2024 · 25 Zit.

Translating the regulatory landscape of medical devices to create fit‐for‐purpose artificial intelligence (<scp>AI</scp>) cytometry solutions

Goce Bogdanoski, Fabienne Lucas, Wolfgang Kern et al.

2024 · 7 Zit.

The Introduction of AI Into Decentralized Clinical Trials

Jana M. Goldberg, Nivee Amin, Krista A. Zachariah et al.

2024 · 6 Zit.

Augmented reality microscopy to bridge trust between AI and pathologists

Sunil Badve, George Louis Kumar, Tobias Lang et al.

2025 · 2 Zit.

MSR80 AI-Enabled Risk of Bias Assessment of RCTs in Systematic Reviews: A Case Study

Julia Langham, T. Reason, Bill Malcolm et al.

2023 · 1 Zit.

Precision medicine: What is so difficult? The interplay and complexities of pharmaceutical and diagnostic partnerships to deliver the promise of precision medicine

Sarah Hersey, Christopher Scott, Steven Rosen et al.

2025 · 0 Zit.

Taking AI Technology Out of the Box: AMWA’s Sixth Medical Writing Executives’ Forum

Janice Worley, Jeanette Towles, John R. Butler et al.

2025 · 0 Zit.

MSR24 AI-Driven Simulation of FDA DCOA Review to Inform Evidence Planning and Regulatory Strategy

Rajdeep Kaur, Sarah M. Donelson, Matthew A. Dixon et al.

2025 · 0 Zit.

AI for evidence-based treatment recommendation in oncology: a blinded evaluation of large language models and agentic workflows

Guannan Zhai, Merav Bar, Andrew J. Cowan et al.

2025 · 0 Zit.

282P Impact of artificial intelligence (AI) on follow-up of incidental lung nodules: A US multi-center ambispective study

Jasleen Pannu, N. S. Hill, M. Viseroi et al.

2025 · 0 Zit.